# A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA

> **NCT02193945** · — · COMPLETED · sponsor: **ThromboGenics** · enrollment: 134 (actual)

## Conditions studied

- Symptomatic Vitreomacular Adhesion (VMA)

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02193945
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-05
- **Final completion:** 2015-05
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2015-07-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02193945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02193945, "A Retrospective Chart Review of Patients Treated With Ocriplasmin for Symptomatic VMA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02193945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*